Investment: Should you invest in ... healthcare?

THE HEALTHCARE sector is a relatively new creation, a varied collection of drug retailers, medical equipment suppliers, private hospitals, nursing homes and companies developing new forms of medical treatment.

The medical services sector is perceived as one of the great growth areas for the millennium, so investors might expect these companies to be showing impressive growth. But healthcare stocks seem to suffer through comparison with their more glamorous cousins in pharmaceuticals and biotech.

The factors affecting all three types of company are broadly similar. Richard Moore of Singer & Friedlander says: "During the second quarter, the US market has led more towards economically sensitive and cyclical stocks. The question we are asking is whether we will see a rotation in the third quarter back into consumer stocks."

Mr Moore believes this is likely, but attention will again focus on companies which make drugs, rather than those which supply them. "The relative rating of cyclical stocks does seem to have peaked in recent weeks, certainly in the US, which tends to led global markets," he says. "And the pharmaceutical sector in the US is trading at a p/e of seven : it has been between five and 50 so it is definitely near the bottom of its range."

David Thornton, UK fund manager for the Witan investment trust, adds: "Pharmaceuticals is a huge sector, with several prominent global players, but the healthcare sector is much smaller and more of a mixed bag. So we would follow only one or two companies in that sector."

Investec Guinness Flight's Alan Beaney says: "The industry background is tough. Those in charge of health budgets are under pressure to cut costs and these guys are relatively easy targets. They are not manufacturing drugs with the security of patent protection and a lot are simply supplying commodity- type products. So there has been a lot of pressure on their pricing, which is why a lot of companies in the sector are coming together to cut costs. The two companies which created of Nycomed Amersham were forced to come together and make a virtue out of a necessity."

Healthcare is usually the least attractive of the three groupings for investors, in activities, and size of the companies. Alan Beaney says: "Healthcare is a small sector in the UK these days. It contains only three major stocks - Nycomed Amersham, Smith & Nephew and SSL International."

David Thornton highlights this last named company, following its creation via a merger of two of the sector's more prominent names. "Seton and Scholl were basically two distributors coming together to rationalise their business. Seton was a drug distributor with good management which added on Scholl's product range."

SSL is also taking over another supplier in a different market. Mr Thornton adds: "SSL is looking to do the same thing with London International, since condoms are distributed through the same outlets. It is the same story of improving distribution, rationalisation and cost cutting, but you have to apply a certain degree of caution about whether there has been sufficient time to bed down the original merger. If you back the management's ability to deliver, then they have a very good opportunity to enhance earnings through the London International acquisition, but it is very much a company specific `special situation'."

Mr Thornton also has a cautious view of Nycomed Amersham. "It has effectively undergone a three-way merger, between the old Amersham International and Nycomed, a Norwegian company, with a Japanese company added in later. It is trying to focus on the areas of nuclear medicine and diagnostic products and it is downplaying its old industrial product range. But it is not an easy company to understand because, when you are putting several companies together, it is difficult to see whether it is working or not."

Anthony Milford, manager of the Framlington Health Fund, says: "Nycomed Amersham has one business that looks particularly interesting, genetic sequencing. But, at the same time, the growth from its prostate cancer treatment has slowed significantly. Some people are also warming to Smith & Nephew. I think it is a better managed company now, but is still not really of interest".

David Thornton says: "Smith & Nephew has been a bit of a sleeper. Its performance has been dull over recent years and a lot its prospects rest on the success of its Dermograph product. Growth has been static, but there is confidence things will pick up. And if you take the view that it is a player in a global growth market with a half-decent franchise, the shares could represent good value, if the management can drive earnings forward." Anthony Milford's unit trust, the highest-profile health sector fund in the UK, hardly holds any companies in the UK healthcare sector. He says: "My major interest is in US biotech companies, where there is a lot more activity and there are many companies making profits. In the UK healthcare sector, you have Nycomed Amersham and Smith & Nephew, both substantial companies, but different in what they do. SSL is a reasonable size, but most other stocks are small, nursing homes, the odd hospital and the like."

Alan Beaney cites the nursing home stocks within the healthcare sector as a prime example of how investments in this area can be blown off course by other forces which are beyond their control. "They have been a little hurt by changes in Government policy. We saw a lot of nursing homes floating a few years ago, but there has been much consolidation. The rules have been tightened up on exactly how much local authorities could spend on nursing homes and, following these `privatisations', you have overcapacity as a result."

Investors will have to look at each stock in the sector on its individual merits. Alan Beaney draws attention to the product of another merger, Alliance Unichem. "We like Alliance Unichem, which is a drug wholesaler and whose chairman is Kenneth Clarke. It came about from a merger between Unichem and Alliance, a French-based pharmaceutical supplier, so they should benefit from growing retail demand in the UK and expansion in Europe."

Alan Beaney points out that the sector remains at the mercy of the purchasers of healthcare services. "The sector is fundamentally suffering from pressure to cut costs, in the UK and the US. It is difficult for health services to cut drugs bills, so they go after the suppliers. In this area, purchasers go to preferred suppliers and seek competitive tendering, so prices tend to get squeezed. Smith & Nephew have had a tough time and they are restructuring."

Richard Moore says: "Pharmaceutical companies have much greater scope to grow their earnings than the healthcare providers, since their driver of growth is the development of new drugs and their release onto the market. Healthcare companies are less involved with that and they are more general service providers."

Start your day with The Independent, sign up for daily news emails
New Articles
tvDownton Abbey Christmas special
Arts and Entertainment
Wolf (Nathan McMullen), Ian (Dan Starky), The Doctor (Peter Capaldi), Clara (Jenna Coleman), Santa Claus (Nick Frost) in the Doctor Who Christmas Special (BBC/Photographer: David Venni)
tvOur review of the Doctor Who Christmas Special
News
peopleIt seems you can't silence Katie Hopkins, even on Christmas Day...
News
news
PROMOTED VIDEO
News
i100
Arts and Entertainment
Left to right: Stanley Tucci, Sophie Grabol and Christopher Eccleston in ‘Fortitude’
tvSo Sky Atlantic arrived in Iceland to film their new and supposedly snow-bound series 'Fortitude'...
Arts and Entertainment
Jenna Coleman as Clara Oswald in the Doctor Who Christmas special
tvForget the rumours that Clara Oswald would be quitting the Tardis
Arts and Entertainment
Japanese artist Megumi Igarashi showing a small mascot shaped like a vagina
art
News
The Queen delivers her Christmas message
newsTwitter reacts to Her Majesty's Christmas Message
Arts and Entertainment
tv
Life and Style
fashion
ebooks
ebooksA year of political gossip, levity and intrigue from the sharpest pen in Westminster
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs Money & Business

Selby Jennings: Oil Operations

Highly Competitive: Selby Jennings: Our client, a leading European Oil trading...

The Jenrick Group: Night Shift Operations Manager

£43500 per annum + pension + holidays: The Jenrick Group: Night Shift Operatio...

SThree: Trainee Recruitment Consultant - LONDON

£20000 - £25000 per annum + OTE £40,000 + Car + Pension: SThree: SThree are a ...

SThree: Trainee Recruitment Consultant

£20000 - £25000 per annum + OTE £35K: SThree: We consistently strive to be the...

Day In a Page

A Christmas without hope: Fears grow in Gaza that the conflict with Israel will soon reignite

Christmas without hope

Gaza fears grow that conflict with Israel will soon reignite
After 150 years, you can finally visit the grisliest museum in the country

The 'Black Museum'

After 150 years, you can finally visit Britain's grisliest museum
No ho-ho-hos with Nick Frost's badass Santa

No ho-ho-hos with Nick Frost's badass Santa

Doctor Who Christmas Special TV review
Chilly Christmas: Swimmers take festive dip for charity

Chilly Christmas

Swimmers dive into freezing British waters for charity
Veterans' hostel 'overwhelmed by kindness' for festive dinner

Homeless Veterans appeal

In 2010, Sgt Gary Jamieson stepped on an IED in Afghanistan and lost his legs and an arm. He reveals what, and who, helped him to make a remarkable recovery
Isis in Iraq: Yazidi girls killing themselves to escape rape and imprisonment by militants

'Jilan killed herself in the bathroom. She cut her wrists and hanged herself'

Yazidi girls killing themselves to escape rape and imprisonment
Ed Balls interview: 'If I think about the deficit when I'm playing the piano, it all goes wrong'

Ed Balls interview

'If I think about the deficit when I'm playing the piano, it all goes wrong'
He's behind you, dude!

US stars in UK panto

From David Hasselhoff to Jerry Hall
Grace Dent's Christmas Quiz: What are you – a festive curmudgeon or top of the tree?

Grace Dent's Christmas Quiz

What are you – a festive curmudgeon or top of the tree?
Nasa planning to build cloud cities in airships above Venus

Nasa planning to build cloud cities in airships above Venus

Planet’s surface is inhospitable to humans but 30 miles above it is almost perfect
Surrounded by high-rise flats is a little house filled with Lebanon’s history - clocks, rifles, frogmen’s uniforms and colonial helmets

Clocks, rifles, swords, frogmen’s uniforms

Surrounded by high-rise flats is a little house filled with Lebanon’s history
Return to Gaza: Four months on, the wounds left by Israel's bombardment have not yet healed

Four months after the bombardment, Gaza’s wounds are yet to heal

Kim Sengupta is reunited with a man whose plight mirrors the suffering of the Palestinian people
Gastric surgery: Is it really the answer to the UK's obesity epidemic?

Is gastric surgery really the answer to the UK's obesity epidemic?

Critics argue that it’s crazy to operate on healthy people just to stop them eating
Homeless Veterans appeal: Christmas charity auction Part 2 - now LIVE

Homeless Veterans appeal: Christmas charity auction

Bid on original art, or trips of a lifetime to Africa or the 'Corrie' set, and help Homeless Veterans
Pantomime rings the changes to welcome autistic theatre-goers

Autism-friendly theatre

Pantomime leads the pack in quest to welcome all